Opportunity
DIBBS #SPE2DP-26-T-3869
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count)
Posted
June 22, 2026
Respond By
June 29, 2026
Identifier
SPE2DP-26-T-3869
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting offers for Moxifloxacin Hydrochloride Tablets. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - OEMs (Original Equipment Manufacturers): - TEVA Pharmaceuticals USA, Inc. - Rising Pharma Holdings, Inc. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Quantity: 2 bottles - TEVA Pharmaceuticals part number: NDC00093-7387-56 - Rising Pharma Holdings part number: NDC57237-0156-30 - Notable Requirements: - Product must comply with FDA regulations - Must meet Medical Marking Standard No. 1A - Packaging must be commercial as specified - Delivery required within 20 days to Fort Campbell, KY - Compliance with Buy American Act and prohibitions on covered defense telecommunications equipment
Description
MOXIFLOXACIN HYDROC (QTY: 2, NSN: 6505-01-503-4772, Purchase Request: 7017224139) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.